Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-2004 | 08-2003 | 08-2002 | 08-2001 | 08-2000 | |
| Sales | 2,160 | 1,470 | 1,060 | 490 | 20 |
| Cost of Goods | 1,410 | 1,280 | 1,430 | 490 | 50 |
| Gross Profit | 750 | 180 | -370 | -4 | -20 |
| Operating Expenses | 3,770 | 4,370 | 4,720 | 4,510 | 2,770 |
| Operating Income | -2,610 | -3,900 | -4,660 | -4,020 | -2,750 |
| Interest Expense | 660 | 0 | 760 | 0 | 60 |
| Other Income | -3,530 | -930 | -80 | 220 | -120 |
| Pre-tax Income | -6,800 | -4,830 | -5,500 | -3,800 | -2,930 |
| Net Income Continuous | -3,822 | 8,134 | -5,516 | -3,803 | -2,936 |
| Net Income Discontinuous | 0 | 0 | -6 | 0 | 0 |
| Net Income | $-6,800 | $-5,090 | $-5,510 | $-3,800 | $-2,930 |
| EPS Basic Total Ops | -0.88 | -0.88 | -1.64 | -1.80 | -6.88 |
| EPS Basic Continuous Ops | -0.49 | 1.39 | -1.38 | -1.69 | -3.65 |
| EPS Diluted Total Ops | -0.88 | -0.88 | -1.64 | -1.80 | -6.88 |
| EPS Diluted Continuous Ops | -0.49 | 1.39 | -1.38 | -1.69 | -3.65 |
| EBITDA(a) | $-590 | $-1,670 | $-2,390 | $-2,040 | $-1,210 |